AP2007004252A0 - A method for the production of a monoclonal antibody to cd20 for the treatment of B-cell lymphoma - Google Patents
A method for the production of a monoclonal antibody to cd20 for the treatment of B-cell lymphomaInfo
- Publication number
- AP2007004252A0 AP2007004252A0 AP2007004252A AP2007004252A AP2007004252A0 AP 2007004252 A0 AP2007004252 A0 AP 2007004252A0 AP 2007004252 A AP2007004252 A AP 2007004252A AP 2007004252 A AP2007004252 A AP 2007004252A AP 2007004252 A0 AP2007004252 A0 AP 2007004252A0
- Authority
- AP
- ARIPO
- Prior art keywords
- treatment
- production
- monoclonal antibody
- cell lymphoma
- lymphoma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN624CH2005 | 2005-05-24 | ||
PCT/IB2006/001358 WO2006126069A2 (en) | 2005-05-24 | 2006-05-24 | A method for the production of a monoclonal antibody to cd20 for the treatment of b-cell lymphoma |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2007004252A0 true AP2007004252A0 (en) | 2007-12-31 |
Family
ID=37452411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2007004252A AP2007004252A0 (en) | 2005-05-24 | 2006-05-24 | A method for the production of a monoclonal antibody to cd20 for the treatment of B-cell lymphoma |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090285795A1 (ko) |
EP (1) | EP1885757A2 (ko) |
JP (1) | JP2009508467A (ko) |
KR (1) | KR20080039844A (ko) |
CN (1) | CN101273063A (ko) |
AP (1) | AP2007004252A0 (ko) |
AU (1) | AU2006250888A1 (ko) |
BR (1) | BRPI0610203A2 (ko) |
CA (1) | CA2609731A1 (ko) |
IL (1) | IL187478A0 (ko) |
MX (1) | MX2007014673A (ko) |
RU (1) | RU2007147598A (ko) |
WO (1) | WO2006126069A2 (ko) |
ZA (1) | ZA200711010B (ko) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006249087B2 (en) | 2005-05-20 | 2012-05-17 | Lonza Biologics Plc | High-level expression of recombinant antibody in a mammalian host cell |
US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
US20100119457A1 (en) * | 2007-03-30 | 2010-05-13 | Helmut Lenz | Composition of labeled and non-labeled monoclonal antibodies |
KR101163295B1 (ko) * | 2007-06-29 | 2012-07-05 | 에프. 호프만-라 로슈 아게 | 향상된 면역글로불린을 생산하는 중쇄 돌연변이체 |
US8680020B2 (en) | 2008-07-15 | 2014-03-25 | Academia Sinica | Glycan arrays on PTFE-like aluminum coated glass slides and related methods |
TW201014605A (en) | 2008-09-16 | 2010-04-16 | Genentech Inc | Methods for treating progressive multiple sclerosis |
WO2010075249A2 (en) | 2008-12-22 | 2010-07-01 | Genentech, Inc. | A method for treating rheumatoid arthritis with b-cell antagonists |
US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
AR080154A1 (es) | 2010-02-10 | 2012-03-14 | Immunogen Inc | Anticuerpos cd20 y su utilizacion |
KR102287474B1 (ko) * | 2010-02-24 | 2021-08-06 | 이뮤노젠 아이엔씨 | 엽산염 수용체 1 항체와 면역접합체 및 이들의 용도 |
WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
EP2568976B1 (en) | 2010-05-10 | 2015-09-30 | Academia Sinica | Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses |
CA2806855A1 (en) | 2010-08-03 | 2012-02-09 | F. Hoffmann - La Roche Ag | Chronic lymphocytic leukemia (cll) biomarkers |
IL281714B2 (en) | 2011-04-01 | 2023-11-01 | Immunogen Inc | Methods for increasing the effectiveness of FOLR1 cancer therapy |
US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
CA2880701A1 (en) | 2012-08-18 | 2014-02-27 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
AU2013305827A1 (en) | 2012-08-21 | 2015-03-05 | Academia Sinica | Benzocyclooctyne compounds and uses thereof |
DK2890717T3 (da) | 2012-08-31 | 2020-05-11 | Immunogen Inc | Diagnostiske assays og kits til detektering af folatreceptor 1 |
WO2014210397A1 (en) | 2013-06-26 | 2014-12-31 | Academia Sinica | Rm2 antigens and use thereof |
US9981030B2 (en) | 2013-06-27 | 2018-05-29 | Academia Sinica | Glycan conjugates and use thereof |
MY176282A (en) | 2013-08-30 | 2020-07-27 | Immunogen Inc | Antibodies and assays for detection of folate receptor 1 |
US9782476B2 (en) | 2013-09-06 | 2017-10-10 | Academia Sinica | Human iNKT cell activation using glycolipids with altered glycosyl groups |
US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
WO2015109180A2 (en) | 2014-01-16 | 2015-07-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
CN103897059B (zh) * | 2014-03-27 | 2016-03-23 | 中国人民解放军军事医学科学院生物工程研究所 | 抗cd20抗原的抗体l5h7及其应用 |
TWI687428B (zh) | 2014-03-27 | 2020-03-11 | 中央研究院 | 反應性標記化合物及其用途 |
CN103936856A (zh) * | 2014-03-27 | 2014-07-23 | 中国人民解放军军事医学科学院生物工程研究所 | 抗cd20抗原的抗体l4h7及其应用 |
CN103936857A (zh) * | 2014-03-27 | 2014-07-23 | 中国人民解放军军事医学科学院生物工程研究所 | 抗cd20抗原的抗体l5h5及其应用 |
KR101723786B1 (ko) | 2014-03-28 | 2017-04-06 | 가톨릭대학교 산학협력단 | Il―21을 발현하는 중간엽 줄기세포를 포함하는 b 세포 림프종 예방 또는 치료용 조성물 |
JP7093612B2 (ja) | 2014-05-27 | 2022-06-30 | アカデミア シニカ | Bacteroides由来のフコシダーゼおよびそれを使用する方法 |
US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
CN106573971A (zh) | 2014-05-27 | 2017-04-19 | 中央研究院 | 抗cd20醣抗体及其用途 |
JP7062361B2 (ja) | 2014-05-27 | 2022-05-06 | アカデミア シニカ | 抗her2糖操作抗体群およびその使用 |
JP7063538B2 (ja) | 2014-05-28 | 2022-05-09 | アカデミア シニカ | 抗TNFα糖操作抗体群およびその使用 |
AU2015315294B2 (en) | 2014-09-08 | 2020-09-17 | Academia Sinica | Human iNKT cell activation using glycolipids |
US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
TWI736523B (zh) | 2015-01-24 | 2021-08-21 | 中央研究院 | 新穎聚醣結合物及其使用方法 |
CA2994888A1 (en) | 2015-09-17 | 2017-03-23 | Immunogen, Inc. | Therapeutic combinations comprising anti-folr1 immunoconjugates |
JP2019515876A (ja) | 2016-03-08 | 2019-06-13 | アカデミア シニカAcademia Sinica | N−グリカンおよびそのアレイのモジュール合成のための方法 |
AU2017250807A1 (en) | 2016-04-15 | 2018-10-25 | H. Lundbeck A/S. | Anti-PACAP antibodies and uses thereof |
US10538592B2 (en) | 2016-08-22 | 2020-01-21 | Cho Pharma, Inc. | Antibodies, binding fragments, and methods of use |
AU2017370942A1 (en) | 2016-12-07 | 2019-06-13 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
CN108456660A (zh) * | 2017-02-17 | 2018-08-28 | 浙江特瑞思药业股份有限公司 | 生产利妥昔单抗的高表达、高稳定性cho细胞株及其构建方法 |
WO2018183929A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
US20230009902A1 (en) | 2018-06-20 | 2023-01-12 | Progenity, Inc. | Treatment of a disease or condition in a tissue orginating from the endoderm |
US20230041197A1 (en) | 2018-06-20 | 2023-02-09 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
KR20210095165A (ko) | 2018-11-19 | 2021-07-30 | 프로제너티, 인크. | 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스 |
EP4309722A2 (en) | 2019-12-13 | 2024-01-24 | Biora Therapeutics, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
GB202007842D0 (en) | 2020-05-26 | 2020-07-08 | Quell Therapeutics Ltd | Polypeptide useful in adoptive cell therapy |
GB202013477D0 (en) | 2020-08-27 | 2020-10-14 | Quell Therapeutics Ltd | Nucleic acid constructs for expressing polypeptides in cells |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736137A (en) * | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
DK0669836T3 (da) | 1992-11-13 | 1996-10-14 | Idec Pharma Corp | Terapeutisk anvendelse af kimære og radioaktivt mærkede antistoffer og humant B-lymfocytbegrænset differentieringsantigen til behandling af B-cellelymfom |
IL157142A0 (en) * | 2001-01-29 | 2004-02-08 | Idec Pharma Corp | Modified antibodies and methods of use |
DE10356112A1 (de) * | 2003-11-27 | 2005-06-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem in den Prostglandinstoffwechsel eingreifendem Wirkstoff |
-
2006
- 2006-05-24 AP AP2007004252A patent/AP2007004252A0/xx unknown
- 2006-05-24 CA CA002609731A patent/CA2609731A1/en not_active Abandoned
- 2006-05-24 RU RU2007147598/13A patent/RU2007147598A/ru not_active Application Discontinuation
- 2006-05-24 US US11/914,750 patent/US20090285795A1/en not_active Abandoned
- 2006-05-24 KR KR1020077029876A patent/KR20080039844A/ko not_active Application Discontinuation
- 2006-05-24 CN CNA2006800269789A patent/CN101273063A/zh active Pending
- 2006-05-24 BR BRPI0610203-4A patent/BRPI0610203A2/pt not_active Application Discontinuation
- 2006-05-24 MX MX2007014673A patent/MX2007014673A/es not_active Application Discontinuation
- 2006-05-24 WO PCT/IB2006/001358 patent/WO2006126069A2/en active Application Filing
- 2006-05-24 AU AU2006250888A patent/AU2006250888A1/en not_active Abandoned
- 2006-05-24 EP EP06744761A patent/EP1885757A2/en not_active Ceased
- 2006-05-24 JP JP2008512943A patent/JP2009508467A/ja active Pending
-
2007
- 2007-11-19 IL IL187478A patent/IL187478A0/en unknown
- 2007-12-19 ZA ZA200711010A patent/ZA200711010B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL187478A0 (en) | 2008-02-09 |
JP2009508467A (ja) | 2009-03-05 |
BRPI0610203A2 (pt) | 2010-06-01 |
AU2006250888A2 (en) | 2008-04-17 |
WO2006126069A2 (en) | 2006-11-30 |
ZA200711010B (en) | 2008-11-26 |
MX2007014673A (es) | 2008-04-08 |
WO2006126069A3 (en) | 2007-10-04 |
CN101273063A (zh) | 2008-09-24 |
KR20080039844A (ko) | 2008-05-07 |
US20090285795A1 (en) | 2009-11-19 |
EP1885757A2 (en) | 2008-02-13 |
CA2609731A1 (en) | 2006-11-30 |
AU2006250888A1 (en) | 2006-11-30 |
RU2007147598A (ru) | 2009-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL187478A0 (en) | A method for the production of monoclonal antibody to cd20 for the treatment of b-cell lymphoma | |
HRP20181565T1 (hr) | Monoklonska protutijela protiv klaudina-18 za liječenje karcinoma |